Doctor profile · Federal record
Dr. Carly Durham, FNP-C
Family Nurse Practitioner (CMS: Nurse Practitioner) · Bellaire, TX
- NPI 1801292313
- Accepts Medicare
- MIPS 49.4 / 100 · 2023
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4710 Bellaire Blvd Ste 340
Bellaire, TX 774014526
(713) 860-1755 - Mailing address
-
123 4Th St
Sugar Land, TX 774982615
Credentials & registration
- NPI registered
- November 2014 — 12 yrs on file
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #AP126710
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801292313. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
771
Distinct HCPCS
3
Medicare allowed
$19,720
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 720 | 11 | $23 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 30 | 12 | $55 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | 16 | $63 |
In context: peer comparison
Among 17 peers in Bellaire Family Nurse Practitioner, average services per provider: 1,467. This provider delivers 0.5× the peer median.Frequently asked questions
What is Dr. Carly Durham's medical specialty?
Dr. Carly Durham practices Family Nurse Practitioner in Bellaire, TX.
Where does Dr. Carly Durham practice?
Dr. Carly Durham practices at 4710 Bellaire Blvd Ste 340, Bellaire, TX 774014526. Office phone: 7138601755.
What is Dr. Carly Durham's NPI?
Dr. Carly Durham's National Provider Identifier (NPI) is 1801292313, issued by NPPES.
Does Dr. Carly Durham accept Medicare assignment?
Yes. Dr. Carly Durham accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Carly Durham commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Infusion into a vein for therapy, prevention, or diagnosis (HCPCS 96365); Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS 96401). Source: CMS Medicare Physician & Other Practitioners file.